impact factor
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER12154Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study20.00 €
 Subtotal 20.00 €